Distinguished in Atherosclerosis

Dr. Habib Samady

Interventional Cardiology | Cardiology
743 Spring St Ne, 
Gainesville, GA 
Accepting New Patients
Offers Telehealth
30 Years of Experience
Distinguished in Atherosclerosis
743 Spring St Ne, 
Gainesville, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Habib Samady is an Interventional Cardiologist and a Cardiologist in Gainesville, Georgia. Dr. Samady has been practicing medicine for over 30 years and is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Coronary Heart Disease, Angina, Atherosclerosis, Percutaneous Coronary Intervention (PCI), and Angioplasty. Dr. Samady is currently accepting new patients.

His clinical research consists of co-authoring 238 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 33 articles and participated in 2 clinical trials in the study of Atherosclerosis.

Specialties
Interventional Cardiology
Cardiology
Licenses
Internal Medicine in VA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

743 Spring St Ne, Gainesville, GA 30501

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

IMPact on Revascularization Outcomes of intraVascular Ultrasound Guided Treatment of Complex Lesions and Economic Impact (IMPROVE)
IMPact on Revascularization Outcomes of intraVascular Ultrasound Guided Treatment of Complex Lesions and Economic Impact (IMPROVE)
Enrollment Status: Active_not_recruiting
Publish Date: September 12, 2025
Intervention Type: Device
Study Phase: Not Applicable
Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Trial A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Trial A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Procedure, Device
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: October 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Enrollment Status: Completed
Publish Date: October 11, 2023
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of WSS and Neointimal Healing Following Percutaneous Coronary Intervention of Angulated Vessels With Resolute® Integrity Zotarolimus Eluting Coronary Stent Compared to XIENCE Xpedition® Everolimus Eluting Coronary Stent
Evaluation of WSS and Neointimal Healing Following Percutaneous Coronary Intervention of Angulated Vessels With Resolute® Integrity Zotarolimus Eluting Coronary Stent Compared to XIENCE Xpedition® Everolimus Eluting Coronary Stent
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
DEFINE PCI: Physiologic Assessment of Coronary Stenosis Following PCI
DEFINE PCI: Physiologic Assessment of Coronary Stenosis Following PCI
Enrollment Status: Completed
Publish Date: May 10, 2022
Intervention Type: Diagnostic test
A Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy of Tirofiban Using a High-Dose Bolus Plus a Shortened Infusion Duration Versus Label-Dosing Eptifibatide in Patients Undergoing Percutaneous Coronary Intervention
A Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy of Tirofiban Using a High-Dose Bolus Plus a Shortened Infusion Duration Versus Label-Dosing Eptifibatide in Patients Undergoing Percutaneous Coronary Intervention
Enrollment Status: Completed
Publish Date: May 13, 2021
Intervention Type: Drug
Study Phase: Phase 2
Radiographic Imaging Validation and EvALuation for Angio iFR (ReVEAL iFR)
Radiographic Imaging Validation and EvALuation for Angio iFR (ReVEAL iFR)
Enrollment Status: Completed
Publish Date: April 01, 2021
Intervention Type: Diagnostic test
Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis
Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis
Enrollment Status: Completed
Publish Date: May 21, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

238 Total Publications

Pericoronary Adipose Tissue Attenuation in Patients with Future Acute Coronary Syndromes: The ICONIC Study.
Pericoronary Adipose Tissue Attenuation in Patients with Future Acute Coronary Syndromes: The ICONIC Study.
Journal: Radiology. Cardiothoracic imaging
Published: June 20, 2025
Similar Doctors
Elite in Atherosclerosis
Dr. Andrew J. Klein
Interventional Cardiology | Cardiology
Elite in Atherosclerosis
Dr. Andrew J. Klein
Interventional Cardiology | Cardiology

Piedmont Cardiology Of Atlanta, LLC

1968 Peachtree Rd Nw, 
Atlanta, GA 
 (47.6 miles away)
404-605-5000
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Klein is an Interventional Cardiologist and a Cardiologist in Atlanta, Georgia. Dr. Klein is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Peripheral Artery Disease, Atherosclerosis, Coronary Heart Disease, Lithotripsy, and Embolectomy. Dr. Klein is currently accepting new patients.

Arshed A. Quyyumi
Distinguished in Atherosclerosis
Dr. Arshed A. Quyyumi
Cardiology
Distinguished in Atherosclerosis
Dr. Arshed A. Quyyumi
Cardiology

Emory Heart & Vascular Center At Executive Park

1605 Chantilly Drive Northeast, Ste301, 
Atlanta, GA 
 (45.6 miles away)
404-778-2746
Experience:
48+ years
Languages Spoken:
English
See accepted insurances

Arshed Quyyumi is a Cardiologist in Atlanta, Georgia. Dr. Quyyumi has been practicing medicine for over 48 years and is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Heart Attack, Bone Marrow Aspiration, and Heart Transplant.

Distinguished in Atherosclerosis
Dr. Paolo Raggi
Cardiology
Distinguished in Atherosclerosis
Dr. Paolo Raggi
Cardiology
1365 Clifton Rd Ne, 
Atlanta, GA 
 (45.6 miles away)
404-778-5414
Languages Spoken:
English
See accepted insurances

Paolo Raggi is a Cardiologist in Atlanta, Georgia. Dr. Raggi is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Heart Attack, and Vasoconstriction.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Samady's expertise for a condition
ConditionClose
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile